Papillomviren und Krebs. Wie aus einem Anfangsverdacht ein Impfstoff wurde |
| |
Authors: | Lutz Gissmann Prof Dr Lysann Schädlich Tilo Senger |
| |
Institution: | Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 242, D‐69120 Heidelberg |
| |
Abstract: | Since a long time epidemiologic studies suggested a sexually transmitted infectious agent as cause of cervical cancer. Human papillomaviruses (HPV) were considered as causative agents since members of the papillomavirus family can induce tumors in animals, and genital infections with papillomaviruses in man are common. Several discoveries ranging from the identification of the plurality of HPVs, the regular finding of genomes of certain, so called high‐risk HPV types within tumor biopsies, insights into the transforming mechanism and informative epidemiological surveys finally led to the conclusion within the scientific community of a causative link between these viruses and cervical cancer as well as other human malignancies. This awareness triggered the development of HPV‐specific vaccines as means of cancer prevention. |
| |
Keywords: | |
|
|